Fruity Pebbles | 56.08mg Per Tablet

Alkaloid Profile (Per Tablet)

Total Alkaloid Content: 56.08 mg

7-Hydroxymitragynine: 98.47% (55.22mg)

Mitragynine Pseudoindoxyl: 1.53% (0.86mg)

Packaging Information

Packaging: Blue to green to yellow mylar

Single Pack: 5 tablets per pack

Multipack: 50 tablets per pack

Product Description

Fruity Pebbles is a high-potency tablet formulation designed to provide consistent relief, sustained effectiveness, and reliable performance for experienced users. While the flavor profile is light and familiar, the formulation itself is engineered for strength, balance, and predictable results.

This tablet is produced using premium Nova Nectar powder and pressed using an American-style formulation process that prioritizes uniformity, durability, and accurate dosing. The result is a smooth, clean tablet with minimal grit and dependable absorption, allowing the effects to build steadily without abrupt spikes.

The alkaloid profile is driven by a very high concentration of 7-Hydroxymitragynine, supporting pronounced physical relief, relaxation, and extended duration. A carefully measured inclusion of Mitragynine Pseudoindoxyl adds stability and balance, helping maintain clarity and functional control while enhancing the overall effectiveness of the formulation.

Fruity Pebbles is well suited for individuals managing ongoing physical discomfort, elevated tolerance levels, or demanding daily routines that require dependable, long-lasting support. Despite its approachable flavor, this is a serious formulation intended to deliver meaningful relief rather than mild or short-term effects.

Caution & Responsible Use

This product is intended for experienced users only. Fruity Pebbles contains a high total alkaloid concentration and should be used responsibly. Begin with a small amount, allow adequate time for full effects to develop, and avoid premature re-dosing. Proper spacing and moderation are essential to ensure safe and effective use.

This product is not available for shipment to the following states: Alabama, Arkansas, Indiana, Rhode Island, Wisconsin, Florida; or the following counties: San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi), Ascension (Louisiana), Franklin (Louisiana), Ohio, and Rapides (Louisiana).

FDA Disclaimer:

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease.

Kratom products have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for safety, effectiveness, or as a treatment for any medical condition. The information provided on this website is for educational purposes only and should not be construed as medical advice. Kratom is not intended to diagnose, treat, cure, or prevent any disease.